When SFN treatment was evaluated in frataxin-silenced motor neuron-like cells [180], neural stem cells isolated from the KIKO FRDA mouse model [181] and also in FRDA fibroblasts [182], this antioxidant was able to revert the cellular phenotypic defects, providing neuroprotection in the neuronal models. Here, FXN is linked to Friedreich ataxia.